CARDIOLITE-413: A Study for Patients Who Had a PCI for an Acute MI

Lantheus Medical Imaging

Status and phase: Completed; Phase 4

Conditions: Myocardial Infarction

Treatments: Drug: Technetium Tc99m Sestamibi

Study type: Interventional

Funder types: Industry

Identifiers

NCT00162331

CARDIOLITE-413

Details and patient eligibility

About

The purpose of this clinical study is to learn if there are any changes in how blood gets to your heart muscle and if your heart size changed after your heart attack.

Enrollment: 74 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Undergoing primary or rescue PCI for acute MI with ECG evidence of a large territory at risk.

Exclusion criteria

• History of prior MI or CABG surgery, persistent LBBB, Atrial Fibrillation, End stage renal disease, Weight > 350 lbs.

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)